Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus ...

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

Unlike therapies used later in cancer treatment, the HPV vaccine targets the virus at its earliest stage, using virus-like particles that look like HPV's outer shell but carry no viral DNA.

Medicus Pharma Ltd ( (MDCX)) has shared an announcement. Medicus Pharma has released an interpretation of Phase 2 data for its SkinJect microneedle delivery system in basal cell carcinoma, ...

mRNA-1345, a lipid nanoparticle encapsulated messenger RNA (mRNA)-based vaccine, was well tolerated and immunogenic in solid organ transplant recipients, inducing neutralizing antibodies against ...

With an orientated development based on scientific nutrition, VitaDairy (Vietnam) has officially introduced its new ColosBaby Lactoferrin - a nutritional formula, which is utilized with many superior ...

ImmunityBio, Inc. (NASDAQ:IBRX) is among the 12 Best Performing Stocks in February. On March 4, 2026, Piper Sandler analyst Patrick Soon-Shiong increased ImmunityBio, Inc. (NASDAQ:IBRX)’s price ...